Pharmacological activity of DC-015, a novel potent and selective α1-adrenoceptor antagonist

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 1, 1996, Pages 90-95

  Yen, M H ^a   Sheu, J R ^a   Peng, I H ^a   Lee, Y M ^a   Chern, J W ^a  

^a NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

3 [[4 (2 METHOXYPHENYL)PIPERAZIN 1 YL]METHYL] 2,3 DIHYDROIMIDAZO [1,2C]QUINAZOLIN 5(6H) ONE; ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; CYCLIC AMP; DC 015; INOSITOL PHOSPHATE; PHENYLEPHRINE; PRAZOSIN; QUINAZOLINE DERIVATIVE; SEROTONIN RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENCY; FEMALE; HEART RATE; INTRAVENOUS DRUG ADMINISTRATION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; RAT; THORACIC AORTA; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION;

EID: 0029997686     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb05884.x     Document Type: Article

References (29)

1. Berridge, M. J. (1984) Inositol trisphosphate and diacyl-glycerol as second messengers. Biochem. J. 220: 345-360
2. Berridge, M. J., Downes, C. P., Hanley, M. R. (1982) Lithium amplifies agonist-dependent phosphoinositol response in brain and salivary glands. Biochem. J. 206: 587-595
3. 2-adrenergic receptors. Int. Rev. Neurobiol. 24: 343-431
4. 1-adrenergic blocking agents and prazosin. Med. J. Aust. 5 (suppl. 2): 2-5
5. 1-adrenoceptor antagonist and antihypertensive agents. J. Med. Chem. 36: 2196-2207
6. Constantine, J. W., Weeks, R. A., McShane, W. K. (1978) Prazosin and presynaptic α-receptors in the cardioaccelerator nerve of the dog. Eur. J. Pharmacol. 50: 51-60
7. Fozard, J R. (1982) Mechanism of the hypertensive effects of ketanserin. J Cardiovasc. Pharmacol. 4: 829-838
8. Graham, R. M., Pettinger, W. A. (1979) Drug therapy. prazosin N. Engl. J. Med. 300: 232-236
9. Graham, R. M., Oates, H. F., Stoker, L. M., Stokes, G. S. (1977) Alpha-blocking action of the antihypertensive agent, prazosin. J. Pharmacol. Exp. Ther. 201: 747-752
10. Hardey, D. W., Lokhandwala, M. F. (1979) Influence of prazosin on cardiac reflex function. Eur. J. Pharmacol. 57: 251-254
11. Hirata, M., Kohse, K.P., Chang, C. H., Ikebe, T., Murad, F. (1990) Mechanism of cyclic GMP inhibition of inositol phosphate formation in rat aorta segment and cultured bovine aortic smooth muscle cells. J. Biol. Chem. 265: 1267-1273
12. 1-adrenoceptors in the spinally anesthetized dog. Eur. J. Pharmacol. 131: 257-264
13. Itoh, T., Izumi, H., Kuriyama, H. (1982) Mechanisms of relaxation induced by activation of β-adrenoceptors in muscle cells of guinea pig mesenteric artery. J. Physiol. 326: 475-493
14. Jaffe, E. A. (1985) Physiological functions of normal endothelial cells. Ann. NY Acad. Sci 454: 279-291
15. Kalkman, H. O., Timmermans, P. B. M. W. M., Van Zwieten, P. A. (1982) Characterization of the antihypertensive properties of ketanserin (R41468) in rats. J. Pharmacol. Exp. Ther. 222: 227-231
16. Kauffman, R. F., Schenck, K. W., Utterback, B. G., Crown, V. G., Cohen, M. L. (1987) In vitro vascular relaxation by new inotropic agents: relationship to phosphodiesterase inhibition and cyclic nucleotides. J. Pharmacol. Exp. Ther. 242: 864-871
17. Lowry, D. H., Rosebrough, N. J., Farr, S. L., Randall, R. J. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275
18. 2 and affinity constants for pharmacological competitive antagonists be estimated? J. Pharm. Pharmacol. 30: 312-313
19. Murad, F. (1986) Cyclic guanosine monophosphate as a mediator of vasodilation. J. Clin. Invest. 78: 1-5
20. 1-adrenoceptors in rat kidney mediates increased inositol phospholipid hydrolysis. Br. J. Pharmacol. 91: 367-376
21. Ousterhout, J. M., Sperelankis, N. (1987) Cyclic nucleotides depress action potentials in cultured aortic smooth muscle cells. Eur. J. Pharmacol. 144: 7-14
22. Palmer, R. J. H., Ferrige, A G., Moncada, S. (1987) Nitric oxide release accounts for the biological activity of endothelium derived relaxing factor. Nature 327: 524-526
23. Person, B., Yao, T., Thorne, P. (1981) Correlation between decreased heart rate and central inhibition of sympathetic discharges after prazosin administration in the spontaneously hypertensive rat. Clin Exp. Hypertension 3: 245-250
24. Stanaszek, W. F., Kellerman, D., Brogden, R. N. (1983) Prazosin update. A review of its pharmacological properties and therapeutic use in hypertension and congestive heart failure. Drugs 25: 339-384
25. Timmermans, P. B. M. W. M., Van Zwieten, P. A. (1984) α-Adrenoceptor agonists and antagonists. Drugs Future 9: 41-55
26. 2 serotonergic receptors. J. Pharmacol. Exp. Ther. 218: 217-230
27. Van Zwieten, P. A. (1990) α-Adrenoceptor antagonists. In: Ganten, D., Mulrow, P. J. (eds) Handbook Exp. Pharmacol.: Pharmacology of Antihypertensive Therapeutics. Springer Verlag, New York, pp 105-125
28. Vanhoutte, P. M., Rubany, G M., Miller, V. M., Houston, D. S. (1986) Modulation of vascular smooth muscle contraction by endothelium. Ann. Res. Physiol. 48: 307-320
29. Young, R. A., Brogden, R. N. (1988) Doxazosin. a review of its pharmacodynamic and pharmacokinetics properties, and therapeutic efficacy in mild or moderate hyptertension. Drugs 35: 525-541